TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Insulin Pumps, Continuous Glucose Monitoring, Closed Loop Insulin Delivery Systems and

Devices and instruments for transfusion and infusion
Industry specific software package
Infusion pumps
+1 more
UK
Published value
Not published
Submission deadline Not published
Lots published3
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Supply Chain Operated by DHL Supply Chain Limited acting as agent of Supply Chain Coordination Ltd (SCCL): "Insulin Pumps, Continuous Glucose Monitoring, Closed Loop Insulin Delivery Systems and". Published status: complete. Published value: Value not published. 3 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS Supply Chain Operated by DHL Supply Chain Limited acting as agent of Supply Chain Coordination Ltd (SCCL)Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS Supply Chain Operated by DHL Supply Chain Limited acting as agent of Supply Chain Coordination Ltd (SCCL)
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS Supply Chain Operated by DHL Supply Chain Limited acting as agent of Supply Chain Coordination Ltd (SCCL). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
12.5Bids / Report
25% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 4 active published awards; 4 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published20 Dec 2022, 09:42 GMT
Last source update20 Dec 2022, 09:42 GMT
Recurring procurementNot published
ClassificationDevices and instruments for transfusion and infusion, Industry specific software package, Infusion pumps, Infusion supplies
Delivery area
UK
OCIDocds-h6vhtk-03494c
What is being bought
In January 2022 NHS Supply Chain launched a non-exclusive Framework Agreement for supply to NHS Supply Chain customer base of Insulin Pumps Continuous Glucose Monitoring Closed Loop Insulin Delivery Systems and Associated Products. The Framework Agreement provides one ordering platform for all technologies, the objective to award broadly across the Framework Agreement to ensure continuity of supply for all key product areas and to also allow optimisation opportunities to be identified. In accordance with Section 3 of the ITT that was published in 2021, NHS Supply Chain has taken the decision to open the Framework Agreement to new Applicants to ensure the Framework Agreement continues to offer the broadest possible range of products to the NHS, as well as ensuring any new technologies and innovations in this product area are made available via the Framework Agreement. Applicants successfully awarded to the Framework Agreement during this Agile Tender will be awarded with the incumbent suppliers who were awarded to the Framework Agreement following the previous tendering exercise (Contract Award Notice reference: 2022/S 000-000260 which can be viewed at: https://www.gov.uk/find-tender).This agreement is for the supply of Insulin Pumps, Continuous Glucose Monitoring (CGM) devices, Applications or software to enable the function of Closed Loop Insulin Delivery Systems and also for the dedicated consumables and accessories for the products listed above. The Framework Agreement was launched in January 2022 with an initial term of 24 months with an option to extend incrementally for up to a total period of 48 months. Applicants successfully awarded to the Framework Agreement during this Agile Tender will therefore be awarded for an initial period of 12 months, with an option to extend incrementally for up to a total period of 36 months. It is anticipated that in the first 12 months of the Framework Agreement the value of the purchases will be circa £20,000,000. For the full 36 month term (if extended) the anticipated value is circa £75,000,000. These values are approximate only and are based on the most recent historical usage information, with a forecasted level of growth. The values provided are for guidance only and are not a guarantee of business or volumes to be purchased from any Supplier.
What changed
From the official release history
  1. tender value changed
    20 Dec 2022, 09:42 GMT
  2. Status changed to complete
    20 Dec 2022, 09:42 GMT
  3. Official notice release published
    20 Dec 2022, 09:42 GMT
  4. Submission deadline changed to published date
    20 Dec 2022, 09:42 GMT
  5. Published value updated to £75,000,000
    31 Aug 2022, 15:44 BST
  6. Status changed to active
    31 Aug 2022, 15:44 BST
  7. Official notice release published
    31 Aug 2022, 15:44 BST
  8. Submission deadline changed to 28 Sept 2022, 15:00 BST
    31 Aug 2022, 15:44 BST
  9. Buyer information updated
    31 Aug 2022, 15:44 BST
  10. Published value updated to £100,000,000
    22 Jun 2022, 14:53 BST
  11. Status changed to planned
    22 Jun 2022, 14:53 BST
  12. Official notice release published
    22 Jun 2022, 14:53 BST
  13. Buyer information updated
    22 Jun 2022, 14:53 BST
Lots and requirements (3)
Published by the contracting authority
  • Lot 1 · #1
    Insulin Pumps
    cancelled
    Published valueNot published
    This lot is for Standalone Insulin Pumps and also Tethered Insulin Pumps, Patch Insulin Pumps, Tethered Pump with Integrated Continuous Glucose Monitor, Patch Pumps with Integrated Continuous Glucose Monitor, Tethered Pump with Integrated Continuous Glucose Monitor and Algorithm. This Lot also includes, but is not limited to; Insulin subcutaneous infusion set Tubes Cannula’s Needle cartridges Handsets Insertion Devices Adaptors Batteries Carry Cases Belts Remotes Sensors Finger Prickers Battery caps Resevoirs USB Adapters Clips Luer Locks Dressings Pouches Service packs Any other option or accessory used with or to configure the pumps. Additional information: Anticipated expenditure will be circa £9,000,000 for the two years of this framework agreement, this is approximate and may vary depending on the requirements of bodies purchasing under the agreement. For the full 36 month term (if extended) the anticipated value is circa £27,000,000. These values are approximate, based on historical usage information, with a forecasted level of growth.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Continuous Glucose Monitors
    cancelled
    Published valueNot published
    This lot is for standalone CGM and Flash Glucose Monitoring. This Lot also includes Receivers, Transmitters, Sensors and Flash Glucose Monitoring Devices. This lot includes but is not limited to: Handsets Sensors Carry cases Tapes Finger prickers Clips Dressings Adhesives Insertion devices Testers Service Packs Download Features Any other option or accessory used to configure the unit. Additional information: Anticipated expenditure will be circa £3,750,000 in the first year of this framework agreement, this is approximate and may vary depending on the requirements of bodies purchasing under the agreement.For the full 36 month term (if extended) the anticipated value is circa £10,875,000. These values are approximate, based on historical usage information, with a forecasted level of growth.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    Software and Diabetes Management Systems
    cancelled
    Published valueNot published
    This lot is for Applications, Software or Algorithms that contribute to the functionality of a Closed/Semi Closed Loop Insulin Delivery System and Diabetes Management Systems that allow for the uploading of information from Insulin Pumps, CGM’s, Glucose Meters and/or Mobile Applications. Mobile applications that act only as an Insulin Pump or CGM controller must not be included in this lot and must instead be submitted as an accessory in the relevant lot where the Pump or CGM device sits. Additional information: Anticipated expenditure will be circa £3,000,000 for the two years of this framework agreement, this is approximate and may vary depending on the requirements of bodies purchasing under the agreement.For the full 36 month term (if extended) the anticipated value is circa £9,000,000. These values are approximate, based on historical usage information, with a forecasted level of growth.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    20 Dec 2022, 09:42 GMT
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award unsuccessful
    Not published · Not published
  5. Contract active
    Signed 22 Nov 2022, 00:00 GMT · £9,000,000
  6. Contract active
    Signed 22 Nov 2022, 00:00 GMT · £3,750,000
Commercial outcome and competition
Awards
Roche Diabetes Care Limited, TLB Medical Supplies Ltd
Not published · Not published · active
TLB Medical Supplies
Not published · Not published · active
Software and Diabetes Management Systems
Not published · Not published · unsuccessful
Contracts
Insulin Pumps
£9,000,000 · signed 22 Nov 2022, 00:00 GMT · active
Continuous Glucose Monitors
£3,750,000 · signed 22 Nov 2022, 00:00 GMT · active
Bid statistics
bids: 2
bids: 1
electronicBids: 2
electronicBids: 1
foreignBidsFromNonEU: 2
foreignBidsFromNonEU: 1
smeBids: 2
smeBids: 1
Buyer and organisations in this procedure

NHS Supply Chain Operated by DHL Supply Chain Limited acting as agent of Supply Chain Coordination Ltd (SCCL)

Contracting authority GB-FTS-56177
View buyer profile
  • NHS Supply Chain Operated by DHL Supply Chain Limited acting as agent of Supply Chain Coordination Ltd (SCCL)
    buyer
    centralPurchasingBody

    Wellington House, 133-155 Waterloo Road, London, UKI4, SE1 8UG
  • Not Applicable
    reviewBody

    Not Applicable
  • Roche Diabetes Care Limited
    supplier

    09055599 
    Burgess Hill, UKJ27, RH15 9RY
  • TLB Medical Supplies
    supplier

    13410609
    Nelson, UKD4
  • TLB Medical Supplies Ltd
    supplier

    13410609
    Nelson, UKD4
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published